|1.||Minami, Yuichiro: 4 articles (09/2015 - 01/2010)|
|2.||Sherrid, Mark V: 4 articles (05/2012 - 04/2005)|
|3.||Hagiwara, Nobuhisa: 3 articles (09/2015 - 01/2010)|
|4.||Lafuente-Lafuente, Carmelo: 3 articles (01/2015 - 04/2006)|
|5.||Bergmann, Jean-François: 3 articles (01/2015 - 04/2006)|
|6.||Kajimoto, Katsuya: 3 articles (11/2010 - 01/2010)|
|7.||Komatsu, Takashi: 3 articles (09/2010 - 04/2003)|
|8.||Haruki, Shintaro: 2 articles (09/2015 - 01/2010)|
|9.||Belmin, Joël: 2 articles (01/2015 - 01/2012)|
|10.||Kawana, Masatoshi: 2 articles (05/2010 - 01/2010)|
07/01/1985 - "When used for removal of atrial fibrillation paroxysms ritmilen is effective in doses of 1.2-1.7 mg/kg intravenously and in doses of 2.5-3.8 mg/kg per os. "
05/01/1999 - "The purpose of this present study was to test whether P-SAECG mapping system would give any information on the efficacy of disopyramide on the prevention of paroxysmal atrial fibrillation (PAF). "
09/01/2003 - "The efficacy of disopyramide in preventing the recurrence of atrial fibrillation varies with the duration of the previous episode. "
05/01/1999 - "Dispersion of filtered P wave duration by P wave signal-averaged ECG mapping system: its usefulness for determining efficacy of disopyramide on paroxysmal atrial fibrillation."
01/01/1991 - "Efficacy of disopyramide in conversion and prophylaxis of post-thyrotoxic atrial fibrillation."
|2.||Cardiac Arrhythmias (Arrythmia)
01/01/1990 - "The effectiveness of Palpitin was expressed as improvement in 66% of cases (reduction of ectopic beats by 75%), and in 40% of cases complete regression of arrhythmia was achieved. "
05/01/1984 - "The dosage regimen of intravenous disopyramide evaluated was effective in 60% of patients with ventricular arrhythmia, induced no severe toxic effects, and rapidly achieved therapeutic serum levels that were maintained during continuous infusion."
05/01/1977 - "Intravenous therapy with disopyramide in the dosage regimen employed appears to be moderately effective against supraventricular arrhythmia and particularly effective against ventricular arrhythmia with minimal toxicity. "
01/01/1981 - "Efficacy of intravenous disopyramide in acute cardiac arrhythmias."
12/01/1980 - "[Clinical efficacy of disopyramide in the treatment of cardiac arrhythmias (author's transl)]."
08/01/1982 - "Oral disopyramide phosphate is effective in preventing induction of sustained AV reentrant tachycardia in most patients. "
02/01/1985 - "Disopyramide is effective in the treatment of post-operative atrial tachyarrhythmias, but its routine use in this situation may be associated with an unacceptably high incidence of side-effects."
01/01/1984 - "In these 4 patients, oral disopyramide was also effective in preventing spontaneous occurrence of tachycardia. "
06/01/1977 - "Therefore, these data document the therapeutic efficacy of disopyramide in the treatment of refractory life-threatening ventricular tachyarrhythmias."
04/01/1986 - "In this study, the safety and efficacy of long-term therapy with disopyramide phosphate were evaluated in 40 patients with documented, recurrent, symptomatic tachyarrhythmias. "
06/01/1977 - "Intravenous administration of disopyramide resulted in more effective electrical stability in all patients and completely eliminated ventricular tachycardia in six. "
05/01/1984 - "The purpose of our study was to assess the efficacy of Propafenon in comparison with Disopyramide in the long-term treatment of repetitive ventricular tachycardia. "
06/01/1977 - "Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia."
02/01/1981 - "[Induction and termination of ventricular tachycardia by programmed electrical stimulation of heart--a case in which the effect of disopyramide phosphate was confirmed by the stimulation study (author's transl)]."
10/01/1995 - "One patient had a recurrence of a well tolerated ventricular tachycardia on disopyramide. "
|5.||Ventricular Premature Complexes (Premature Ventricular Contraction)
06/01/1989 - "Ritmilen is highly effective in ventricular extrasystole in the presence of slow sinus rhythm."
01/01/1986 - "Disopyramide gave a marked and significant reduction of ventricular ectopic beats both at rest and during and after exercise. "
12/01/1985 - "Low-dose (7 mg/kg per day) disopyramide administration to arrhythmic chagasic patients decreased the frequency of ventricular extrasystoles in 4 of 17 patients (24%) and suppressed most complex ventricular arrhythmias in 12 of 15 patients (80%). "
10/01/1984 - "i. d.) compared to disopyramide (D) (200 mg t.i.d.) was thus investigated using a double-blind crossover placebo-controlled protocol in 12 patients, aged 13 to 67 years, with chronic stable high frequency premature ventricular beats (PVB), defined as greater than 100 PVB/h during 48-72-h control Holter monitoring. "
09/01/1983 - "We tested the safety of multiple bolus loading for intravenous disopyramide in 10 patients with frequent premature ventricular beats. "
|2.||Electric Countershock (Cardioversion)
|5.||Drug Therapy (Chemotherapy)